The SCAN pathway offers a unique opportunity to access one of the UK’s most comprehensive research infrastructures for non-specific cancer symptoms.
The Oxford Suspected Cancer (SCAN) Pathway aims to reduce the time that patients who have vague symptoms that could be cancer wait to be diagnosed. In doing this, it also aims to increase the number of patients that are diagnosed at an early stage in their illness.
SCAN provides:
- Extensive clinical, laboratory, and imaging data
- Biobanked blood and urine samples
- Support for translational and early detection research
